Kyrgyzstan vs Puerto Rico: The number of people with susceptibility test result for rifampicin
Kyrgyzstan
94.01
in 2021
Puerto Rico
93.33
in 2021
Kyrgyzstan rank
56th
Puerto Rico rank
58th
The number of people with susceptibility test result for rifampicin over time
- Kyrgyzstan
- Puerto Rico
How they compare
Kyrgyzstan currently reports 94.01 against 93.33 in Puerto Rico, a difference of 0.68.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Puerto Rico ahead.
Kyrgyzstan ranks 56th and Puerto Rico ranks 58th of 146 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Kyrgyzstan | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 89.91 | 97.81 | 7.91 | Puerto Rico |
| 2020s | 93.02 | 94.49 | 1.48 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Kyrgyzstan or Puerto Rico?
- Kyrgyzstan, at 94.01 against 93.33 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Kyrgyzstan and Puerto Rico?
- 0.68, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do Kyrgyzstan and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- Kyrgyzstan ranks 56th and Puerto Rico ranks 58th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.